Alison Ribeiro

Alison Ribeiro is a highly experienced scientist with a robust background in pharmacology and drug development. Currently serving as a Senior Scientist at Molecular Partners, Alison previously held similar roles at Roche and conducted postdoctoral research at UniversitätsSpital Zürich. With expertise in hit identification for ARID1A-deficient ovarian cancer and the development of high-throughput drug screening assays, Alison's work has involved collaboration on various projects, statistical analysis, and data interpretation. Prior experiences include investigating pharmacological efficacy at Chiesi Group, focusing on the characterization of new compounds, and contributing to lead optimization at IIT - Istituto Italiano di Tecnologia. Alison's academic credentials include a PhD and a Master's degree in Pharmacology from Universidade de São Paulo, as well as a Bachelor's degree in Pharmacy from Universidade Nove de Julho.